News
VisEra, an optical component manufacturer under TSMC, held its shareholders meeting to outline its outlook for 2025. Chairman ...
TAR-200 demonstrated rapid onset at a median 2.8 months with most complete response achieved within the first 3 months. Treatment-related adverse events (TRAEs) occurred in 71 patients with CIS ...
Cretostimogene for CIS-containing BCG unresponsive nonmuscle ... Cretostimogene was found to be very well-tolerated. Grade 1 and 2 related AEs were typically transient (median time to resolution ...
“The Last of Us” Season 2 has finally arrived. This time, it is not just the series’ central two stars who are leading the way, either. Following the template set by its video game source ...
cis-3-Hexene and reference compounds with trichloroacetyl chloride were introduced into the chamber and left in the dark for 2 hours. Under such conditions, no evidence for a reaction between ...
SK Hynix is shutting down its CMOS image sensor (CIS) business, fueling industry speculation over whether Samsung Electronics will follow suit. Samsung's system LSI division, which oversees its ...
(Swedish Armed Forces) Sweden's Defence Materiel Administration (Försvarets materielverk: FMV) has confirmed the delivery of a new command information system (CIS), enabling the Royal Swedish ...
ISLAMABAD: The Securities and Exchange Commission of Pakistan (SECP) has notified new management fee caps for the Collective Investment Scheme (CIS ... Sub-Fund up to 2.00%; (ii) Money Market ...
Image: Genex Power. The successful projects of the first Capacity Investment Scheme (CIS) tender round in Australia have been revealed, with 2.75GW of solar PV being awarded, alongside 3.55GW of wind.
Additionally, a multi-directional phase detection (PD) function is incorporated by stacking a 2×1 on-chip lens and metal shield, allowing for PD across diverse objects with minimal pixel defects. Our ...
SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A randomized phase 3 trial. ctDNA analysis of patients (pts) ...
Elon Musk warned us this was coming. Now, the owner of X (formerly Twitter) has apparently followed through on his threat to begin treating the words “cis” and “cisgender” as slurs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results